1. Home
  2. APLS vs JOE Comparison

APLS vs JOE Comparison

Compare APLS & JOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • JOE
  • Stock Information
  • Founded
  • APLS 2009
  • JOE 1936
  • Country
  • APLS United States
  • JOE United States
  • Employees
  • APLS N/A
  • JOE N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • JOE Homebuilding
  • Sector
  • APLS Health Care
  • JOE Real Estate
  • Exchange
  • APLS Nasdaq
  • JOE Nasdaq
  • Market Cap
  • APLS 3.3B
  • JOE 2.7B
  • IPO Year
  • APLS 2017
  • JOE N/A
  • Fundamental
  • Price
  • APLS $18.20
  • JOE $42.66
  • Analyst Decision
  • APLS Buy
  • JOE
  • Analyst Count
  • APLS 18
  • JOE 0
  • Target Price
  • APLS $45.59
  • JOE N/A
  • AVG Volume (30 Days)
  • APLS 2.8M
  • JOE 298.2K
  • Earning Date
  • APLS 05-06-2025
  • JOE 04-23-2025
  • Dividend Yield
  • APLS N/A
  • JOE 1.31%
  • EPS Growth
  • APLS N/A
  • JOE N/A
  • EPS
  • APLS N/A
  • JOE 1.27
  • Revenue
  • APLS $781,367,000.00
  • JOE $402,737,000.00
  • Revenue This Year
  • APLS $12.71
  • JOE N/A
  • Revenue Next Year
  • APLS $20.93
  • JOE N/A
  • P/E Ratio
  • APLS N/A
  • JOE $33.59
  • Revenue Growth
  • APLS 97.02
  • JOE 3.46
  • 52 Week Low
  • APLS $17.49
  • JOE $40.19
  • 52 Week High
  • APLS $53.06
  • JOE $64.69
  • Technical
  • Relative Strength Index (RSI)
  • APLS 28.14
  • JOE 41.25
  • Support Level
  • APLS $18.00
  • JOE $42.01
  • Resistance Level
  • APLS $19.71
  • JOE $43.13
  • Average True Range (ATR)
  • APLS 1.63
  • JOE 1.78
  • MACD
  • APLS -0.16
  • JOE -0.20
  • Stochastic Oscillator
  • APLS 10.98
  • JOE 34.84

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About JOE St. Joe Company (The)

The St. Joe Co is a real estate development, asset management, and operating company and it has three operating segments; the Residential segment plans and develops residential communities and sells homesites to homebuilders or retail consumers, the Hospitality segment that derives maximum revenue, features a private membership club, hotel operations, food and beverage operations, golf courses, beach clubs, retail outlets, gulf-front vacation rentals, management services, marinas, and other entertainment assets, and Commercial segment include leasing of commercial property, multi-family, senior living, self-storage, and other assets and it also oversees the planning, development, entitlement, management, and sale of commercial and rural land holdings.

Share on Social Networks: